Home - Products - Immunology/Inflammation - NOS - S-Nitroso-N-acetyl-DL-penicillamine

S-Nitroso-N-acetyl-DL-penicillamine

CAS No. 67776-06-1

S-Nitroso-N-acetyl-DL-penicillamine( SNAP )

Catalog No. M22495 CAS No. 67776-06-1

S-Nitroso-N-acetyl-DL-penicillamine acts as a stable inhibitor of platelet aggregation, is a nitric oxide donor and . S-Nitroso-N-acetyl-DL-penicillamine (10 mM; 8 hours) after 6 hours under normoxic conditions by releasing nitric oxide (NO)induces toxicity of about 80% .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 37 In Stock
25MG 51 In Stock
50MG 84 In Stock
100MG 149 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    S-Nitroso-N-acetyl-DL-penicillamine
  • Note
    Research use only, not for human use.
  • Brief Description
    S-Nitroso-N-acetyl-DL-penicillamine acts as a stable inhibitor of platelet aggregation, is a nitric oxide donor and . S-Nitroso-N-acetyl-DL-penicillamine (10 mM; 8 hours) after 6 hours under normoxic conditions by releasing nitric oxide (NO)induces toxicity of about 80% .
  • Description
    S-Nitroso-N-acetyl-DL-penicillamine acts as a stable inhibitor of platelet aggregation, is a nitric oxide donor and . S-Nitroso-N-acetyl-DL-penicillamine (10 mM; 8 hours) after 6 hours under normoxic conditions by releasing nitric oxide (NO)induces toxicity of about 80% . S-Nitroso-N-acetyl-DL-penicillamine has a half-time about 6 hours in in isolated rat ventricular myocytes. S-Nitroso-N-acetyl-DL-penicillamine (100 μM; 30 minutes) causes sustained decrease in the basal pHi in isolated rat ventricular myocytes.
  • In Vitro
    Cell Viability Assay Cell Line:Rat liver sinusoidal endothelial cells Concentration:2 mM, 5 mM, 10 mM Incubation Time:2 hours, 4 hours, 6 hours, 8 hours Result:Exhibited cytotoxicity against cultivated endothelial cells.
  • In Vivo
    ——
  • Synonyms
    SNAP
  • Pathway
    Immunology/Inflammation
  • Target
    NOS
  • Recptor
    NO Synthase
  • Research Area
    Others
  • Indication
    Anesthesia

Chemical Information

  • CAS Number
    67776-06-1
  • Formula Weight
    220.25
  • Molecular Formula
    C7H12N2O4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:250 mg/mL (1135.07 mM; Need ultrasonic)
  • SMILES
    CC(=O)NC(C(O)=O)C(C)(C)SN=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. E. Salas, et al. Comparative pharmacology of analogues of S-nitroso-N-acetyl-DL-penicillamine on human platelets. Br J Pharmacol. 1994 Aug;112(4):1071-6.
molnova catalog
related products
  • NOS-IN-1?

    2-Imino-4-methylpiperidine is a potent, general NOS inhibitor.

  • MEG hemisulfate

    MEG hemisulfate (Mercaptoethylguanidine hemisulfate) acts as a highly potent and selective suppressor of inducible NO synthase (iNOS), demonstrating EC50 values of 11.5 μM for iNOS, 110 μM for ecNOS, and 60 μM for bNOS in tissue homogenates.

  • Tsugaric acid A

    Tsugaric acid A can significantly inhibit superoxide anion formation in fMLP/CB-stimulated rat neutrophils it is also able to protect human keratinocytes against damage induced by ultraviolet B (UV B) light indicates that tsugaric acid A can protect keratinocytes from photodamage.